Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
IPCA Laboratories Limited
IPCALABCurrent price
1 536.55 INR
+41.6 INR (+2.78%)
Last closed
1 504.85 INR
Company
www.ipca.com
ISIN
INE571A01038
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
389 930 319 864 INR
Yield for 12 month
+42.13 %
1Y
3Y
5Y
10Y
15Y
IPCALAB
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India. Address: 125, Kandivli Industrial Estate, Mumbai, India, 400067
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
123 725.21 INRP/E ratio
67.5704Dividend Yield
0.26 %Current Year
+77 058 799 962 INR
Last Year
+62 443 199 991 INR
Current Quarter
+20 926 299 973 INR
Last Quarter
+20 330 100 024 INR
Current Year
+48 584 100 003 INR
Last Year
+39 378 100 007 INR
Current Quarter
+8 623 800 033 INR
Last Quarter
+7 829 799 977 INR
Key Figures IPCALAB
1 year
3 years
5 years
10 years
EBITDA
13 421 949 913 INR
Operating Margin TTM
PE Ratio
67.5704
Return On Assets TTM
5.9 %
PEG Ratio
–
Return On Equity TTM
7.67 %
Wall Street Target Price
123 725.21 INR
Revenue TTM
82 133 000 192 INR
Book Value
249.59 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
31.8 %
Dividend Yield
0.26 %
Gross Profit TTM
40 634 300 000 INR
Earnings per share
22.74 INR
Diluted Eps TTM
22.74 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
18.1 %
Profit Margin
7.02 %
Dividend Analytics IPCALAB
Dividend growth over 5 years
300 %Continuous growth
–Payout Ratio 5 years average
13 %Dividend History IPCALAB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
4
Ex Dividend Date
25.11.2024
Forward Annual Dividend Yield
0.26 %
Last Split Factor
2:1
Payout Ratio
15.34 %
Last Split Date
10.01.2022
Dividend Date
–
Stock Valuation IPCALAB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
67.5704
Forward PE
–
Enterprise Value Revenue
4.8692
Price Sales TTM
4.7475
Enterprise Value EBITDA
28.315
Price Book MRQ
6.1563
Financials IPCALAB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IPCALAB
For 52 weeks
1 039.38 INR
1 708.65 INR
50 Day MA
1 536.57 INR
Shares Short Prior Month
–
200 Day MA
1 326.75 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart